Metagenomic Sequencing Market Analysis
The global metagenomic sequencing market is predicted to grow at a 6.5% CAGR over the forecast period (2017-2023), states the new Market Research Future (MRFR) report. Metagenomics, simply put, is a molecular tool that is used for analyzing DNA that is acquired from environmental samples to study the community of microorganisms present in their natural habitat devoid of the need to obtain pure cultures. This method along with offering species identification, classification, as well as quantitation of microbes, will also at the same time offer information for functional analysis of genes with the help of metabolic pathway analysis and gene ontology. Its key benefit is that metagenomics allows the study and discovery of microbial genomes that otherwise would be intractable owing to cultivation difficulties.
Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @ https://www.marketresearchfuture.com/sample_request/5598
Various factors are propelling the metagenomic sequencing market growth. These factors, as stated by the latest MRFR report, include growing awareness about genetic disorders, improved genomic tools, advanced technological platforms, funding and favorable initiatives undertaken by private bodies and government for large-scale sequencing projects, declining cost of sequencing, and recovery of new drugs. Additional factors propelling market growth include high throughput screening methods, development of cost-effective technologies (next-generation sequencing), increasing research and development for identifying new enzymes and antibiotics, and improved bioinformatics.
On the flip side, lack of knowledge and skilled professionals and rising concerns about accuracy and standardization of diagnostic testing are factors that may impede the metagenomic sequencing market growth over the forecast period.
Metagenomic Sequencing Market Segmentation
The MRFR report provides a complete segmental analysis of the metagenomic sequencing market report on the basis of end user, application, and technology.
Based on technology, the metagenomic sequencing market is segmented into bioinformatics, sequencing, and others.
Based on application, the metagenomic sequencing market is segmented into agriculture, ecology, biofuel, biotechnology, gut microbe characterization, environmental remediation, and infectious disease diagnosis.
Based on end user, the metagenomic sequencing market is segmented into specialized clinics, research institutes, hospitals, and others.
Metagenomic Sequencing Market Regional Analysis
By region, the metagenomic sequencing market report covers the latest trends and growth opportunities across the Asia Pacific, Europe, the Americas, and the Middle East and Africa. Of these, the Americas will lead the market over the forecast period. Factors aiding growth in the region include advancements in technology in the next-generation sequencing methods and its increasing applications.
The metagenomic sequencing market in Europe is predicted to have the second-largest share in the market over the forecast period. Factors aiding growth in the region include increasing investment by government and hospital facilities for better healthcare, increasing use of NGS techniques by research laboratories, low cost of sequencing, and growing partnerships and collaborations.
The metagenomic sequencing market in the APAC region is predicted to grow in the fastest pace over the forecast period. Factors aiding growth in the region include increasing incidence of genetic disorders worldwide, and affordable healthcare & research.
The metagenomic sequencing market in the MEA is predicted to have a steady growth over the forecast period. Factors affecting the market growth in the Middle East region include high cost of tests, limited availability of services and products, traditional healthcare practices, weak research infrastructure and healthcare, and lack of knowledge about genetic disorders and diseases.
Metagenomic Sequencing Market Key Players
Leading players profiled in the metagenomic sequencing market report include Knome Inc. (US), Helicos BioSciences (US), Macrogen Inc. (South Korea), DNAStar Inc. (US), Agilent Technologies Inc. (US), CLC Bio (Qiagen) (Denmark), Oxford Nanopore Technologies Inc. (UK), Thermo Fisher Scientific Inc. (US), Biomatters Ltd. (New Zealand), Beijing Genomics Institute (China), Pacific Biosciences (US), COSMOSID (US), GenapSys, Inc. (US), Freenome Inc. (US), Quest Diagnostics Incorporated (US), Second Genome Therapeutics (US), SciGenom Labs Pvt. Ltd. (India), F Hoffman-La Roche Ltd. (Switzerland), The Mitre Corporation (US), Aperiomics, Inc. (US), Illumina Inc. (US), Enterome Bioscience (France), and Biotech AG (Germany).
June 2019: Cray Inc. will accelerate research on environmental genomics at the SCELSE (Singapore Centre for Environmental Life Sciences Engineering) to address environmental challenges.
Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @ https://www.marketresearchfuture.com/reports/metagenomic-sequencing-market-5598
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.